License Grants to Alnylam. (a) Subject to the terms and conditions of this Agreement, Tekmira hereby grants to Alnylam and its Affiliates an exclusive right and license under the Tekmira Combined Licensed Technology and the Category 1 Patents to Research, Develop and Commercialize Alnylam Products directed to any Alnylam Exclusive Target in the Alnylam Field in the Territory.
Appears in 6 contracts
Samples: Cross License Agreement (Alnylam Pharmaceuticals, Inc.), Cross License Agreement, Cross License Agreement (TEKMIRA PHARMACEUTICALS Corp)